Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.

beta Blockade after myocardial infarction. Beta blockers have key role in reducing morbidity and mortality after infarction.

Nuttall SL, Toescu V, Kendall MJ.

BMJ. 2000 Feb 26;320(7234):581. No abstract available.

2.

[Secondary prophylaxis with beta blockers after myocardial infarction].

Bosković D.

Srp Arh Celok Lek. 1992 Jun;120 Suppl 4:25-34. Review. Serbian.

PMID:
18193807
3.

Post-myocardial infarction trials: beta blockers, antiarrhythmics, thrombolytics.

Anderson JL.

Control Clin Trials. 1996 Jun;17(3 Suppl):17S-27S. Review.

PMID:
8877264
4.

Cardioprotection with beta-adrenoceptor blockers. Does lipophilicity matter?

Hjalmarson A.

Basic Res Cardiol. 2000;95 Suppl 1:I41-5. Review.

PMID:
11192352
6.
7.

Sudden death: ACE inhibitors and beta-blockers.

Landray MJ.

Basic Res Cardiol. 2000;95 Suppl 1:I37-40. Review.

PMID:
11192351
8.

Beta-blocker therapy for secondary prevention of myocardial infarction.

Hoffmann RL, Reeder SJ, Rodgers JM.

Dimens Crit Care Nurs. 2000 Mar-Apr;19(2):2-10; quiz 11-2. Review.

PMID:
10876491
9.

The role of beta-blockers in preventing sudden death in heart failure.

Teerlink JR, Massie BM.

J Card Fail. 2000 Jun;6(2 Suppl 1):25-33. Review.

PMID:
10908095
10.

Clinical trial data on the cardioprotective effects of beta-blockade.

Kendall MJ.

Basic Res Cardiol. 2000;95 Suppl 1:I25-30. Review.

PMID:
11192348
11.
12.

[Secondary prevention after myocardial infarction; role of beta blockaders].

Cohen-Solal A, Seknadji P, Czitrom D, Boudvillain O.

Arch Mal Coeur Vaiss. 1996 Aug;89 Spec No 3:43-6. French.

PMID:
8949318
13.
14.

Beta-adrenergic blockade in the prevention of myocardial infarction: a new theory.

Frishman WH, Chang CM.

J Hypertens Suppl. 1991 Dec;9(7):S31-4.

PMID:
1686459
15.
16.

Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).

Piccini JP, Hranitzky PM, Kilaru R, Rouleau JL, White HD, Aylward PE, Van de Werf F, Solomon SD, Califf RM, Velazquez EJ.

Am J Cardiol. 2008 Dec 1;102(11):1427-32. doi: 10.1016/j.amjcard.2008.07.033. Epub 2008 Sep 11.

PMID:
19026290
17.

Beta-blockers prevent cardiac events in Japanese patients with myocardial infarction.

Ishikawa K, Miyataka M, Kimura A, Takeda N, Hirano Y, Hayashi T, Kanamasa K; Secondary Prevention Group.

Circ J. 2004 Jan;68(1):59-67.

18.

Expert consensus document on beta-adrenergic receptor blockers.

López-Sendón J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C; Task ForceOn Beta-Blockers of the European Society of Cardiology.

Eur Heart J. 2004 Aug;25(15):1341-62. Review. No abstract available.

PMID:
15288162
19.

Outcomes of inappropriate prescribing of beta-blockers after an acute myocardial infarction in a Medicaid population.

Fernandes AW, Madhavan SS, Amonkar MM, Bell D, Islam SS, Scott VG.

Ann Pharmacother. 2005 Sep;39(9):1416-22. Epub 2005 Jun 21.

PMID:
15972326
20.

The role of long term beta-blockade after myocardial infarction: Paper 1.

O'Rourke M.

Aust Fam Physician. 1978 Jun;Suppl:32-3.

PMID:
30441

Supplemental Content

Support Center